Skip to main content
. Author manuscript; available in PMC: 2020 Sep 30.
Published in final edited form as: Int J Cancer. 2017 Oct 16;142(5):1022–1032. doi: 10.1002/ijc.31084

Table 4.

Incidence of ovarian metastasis based on risk factor patterns

Whole cohort (n = 5,481)

Adeno LVSI Uterine corpus Pelvic node Aortic node No. (%) Ov mets (%)

1,423 (26.0%) 0.14%
+ 683 (12.5%) 0.29%
+ 1,248 (22.8%) 0.16%
+ 83 (1.5%) 0%
+ 130 (2.4%) 0%
+ + 287 (5.2%) 1.39%
+ + 54 (1.0%) 0%
+ + 43 (0.8%) 2.33%
+ + 201 (3.7%) 0.99%
+ + 696 (1.27%) 1.0%
+ + 15 (0.3%) 0%
+ + + 76 (1.4%) 7.89%
+ + + 148 (2.7%) 2.03%
+ + + 207 (3.8%) 5.80%
+ + + + 79 (1.4%) 17.7%
+ + + + 23 (0.4%) 26.1%
+ + + + + 11 (0.2%) 36.4%
Age <50 cohort (n = 3,137)
Adeno Parametrea Uterine corpus Pelvic node Aortic node No. (%) Ov mets (%)
1,446 (46.1%) 0.14%
+ 594 (18.9%) 0.17%
+ 113 (3.6%) 0%
+ 74 (2.4%) 0%
+ 337 (10.7%) 0.89%
+ + 25 (0.8%) 4.0%
+ + 38 (1.2%) 5.26%
+ + 86 (2.7%) 1.16%
+ + 35 (1.1%) 0%
+ + 145 (4.6%) 0%
+ + 37 (1.2%) 5.41%
+ + + 16 (0.5%) 6.25%
+ + + 31 (1.0%) 9.68%
+ + + 20 (0.6%) 15.0%
+ + + 68 (2.2%) 4.41%
+ + + + 12 (0.4%) 16.7%
+ + + + 12 (0.4%) 16.7%

Only cases with available results for all the risk factors were analyzed for incidence of ovarian metastasis. Only combination patterns with more than five cases are shown. Abbreviations: Adeno, adenocarcinoma; LVSI, lymphovascular space invasion; and Ov mets, ovarian metastasis.